Ear zaps aim to tame stomach troubles
NCT ID NCT06491758
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether electrically stimulating a nerve in the ear can reach the internal vagus nerve, which controls stomach function. Researchers will measure nerve signals and stomach activity in 131 healthy volunteers and people with gastroparesis. The goal is to see if this ear stimulation method could one day treat nausea, vomiting, and other stomach issues.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- electrical stimulation of the ear
- What this could lead to
- If successful, this could lead to a non-invasive way to treat nausea, vomiting, and stomach disorders by stimulating the vagus nerve through the ear.
- What could go wrong
- This is an early-phase study focused on measuring nerve signals, not on treatment outcomes. It may not lead to a practical therapy, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
131 people
The number who actually took part.
- Started
-
Jun 2020
- Expected to finish
-
Dec 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria healthy volunteers * Healthy volunteers with no gastric symptoms or conditions (except due to COVID 19) * Aged 18-80 years * Willing to have electrodes placed in the external ear (ABVN arm) * Willing to perform vagal activity maneuver (Vagal arm) * Willing to have 1 tablespoon (15 ml) of blood drawn at 3 time points Inclusion Criteria gastroparesis subjects * Gastroparesis subjects with a confirmed diagnosis of gastroparesis from a GI physician * Have a formal diagnosis of gastroparesis or are seeing the GI physician for symptoms related to gastroparesis * Aged 18-80 years * Willing to have electrodes placed in the external ear (ABVN arm) * Willing to perform vagal activity maneuver (Vagal arm) * Willing to have 1 tablespoon (15 ml) of blood drawn at 3 time points Exclusion Criteria: * Unable to provide consent * Pregnant females * Prisoners
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Gastroparesis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Indiana University
Indianapolis, Indiana, 46202, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Ultrasound could reveal when ICU tube feeding fails
- Stomach sensor may unmask hidden effects of weight-loss drugs
- A sticker-based stomach scan may replace radioactive tests for a chronic digestive disorder
- Can a stomach muscle cut tame diabetes blood sugar?
- Could a skin patch ease stomach pain in scleroderma?
- Could a botox shot in the gut ease Kids' chronic vomiting?